Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Guardant Health Inc GH

Healthcare
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer... see more

Recent & Breaking News (NDAQ:GH)

Guardant Health to Participate in Upcoming Investor Conferences

Business Wire February 15, 2024

Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

Business Wire February 1, 2024

Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence

Business Wire January 17, 2024

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results

Business Wire January 8, 2024

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

Business Wire January 8, 2024

Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer

Business Wire January 2, 2024

Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford

Business Wire December 21, 2023

Guardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire December 20, 2023

Guardant Health Announces Tentative Date of FDA Advisory Panel Review of Shield(TM) Blood Test

Business Wire December 19, 2023

Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities

Business Wire December 4, 2023

Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection

Business Wire November 30, 2023

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 15, 2023

Guardant Health to Appeal Federal District Court Verdict

Business Wire November 15, 2023

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

PR Newswire November 12, 2023

Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

Business Wire November 6, 2023

Guardant Health to Participate in Upcoming November Investor Conferences

Business Wire November 3, 2023

Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR® Platform

Business Wire October 31, 2023

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer

Business Wire October 23, 2023

Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Business Wire October 16, 2023

Guardant Health Receives Coverage for Guardant Reveal(TM) from Geisinger Health Plan

Business Wire September 6, 2023